title: Anti-VEGF in retinopathy of prematurity, need to titrate.
authors.affiliation: Angiogenesis Laboratory, Retina Service, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, and Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Vavvas@meei.harvard.edu
authors.forename: Demetrios G
authors.initials: DG
authors.lastname: Vavvas
mesh_terms: D000818:Animals; D000906:Antibodies / Q000494:pharmacology*; D005260:Female; D006801:Humans; D009389:Neovascularization, Pathologic / Q000139:chemically induced* / Q000517:prevention & control*; D010100:Oxygen / Q000037:antagonists & inhibitors*; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage*; D012160:Retina / Q000187:drug effects*; D012164:Retinal Diseases / Q000139:chemically induced*; D012171:Retinal Vessels / Q000187:drug effects* / Q000254:growth & development*; D012178:Retinopathy of Prematurity / Q000188:drug therapy*; D042461:Vascular Endothelial Growth Factor A / Q000494:pharmacology*
chemical_list: D000906:Antibodies; D011993:Recombinant Fusion Proteins; D042461:Vascular Endothelial Growth Factor A; D010100:Oxygen